http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0278877-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86de07505ef9a9cb798c158f2cb9c653
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-35
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
filingDate 1988-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bddfea9d078ea7bee55d0cf0304f61a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1aa0f8dee46719beff7335b99ffe8034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82f1ec49572740dabdb110167b2c7e55
publicationDate 1988-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0278877-A1
titleOfInvention Galenical forms of allergens for sublingual administration
abstract These new galenical forms of allergens are characterized in that said allergens are contained in strictly controlled and reproducible quantities in solid supports intended for a gradual release of the active principle by per- and sub-lingual route.n n n Their preparation process includes the following steps: - dissolving an allergen in a polar solvent to obtain a stock solution; - preparation of dilutions at different concentrations, - splitting of each of these dilutions into under-dilutions, - impregnation by multi-impregnation or fractional impregnation of a solid pharmaceutically acceptable support with each of the sub-dilutions, each of said impregnation steps being followed by drying in forced air and dried at a temperature less than or equal to 30 ° C. ; - protective final impregnation of the coating type.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2952200-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004075875-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8329196-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10080719-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9415015-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10471008-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5591433-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009034110-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015185684-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0590060-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8012505-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2324850-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2436395-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0590060-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2640138-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9408805-B2
priorityDate 1987-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0192321-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6890
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128787717

Total number of triples: 40.